Mobile Psychosocial Interventions for MMT Clients

NCT01632982 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2017-09-14

No results posted yet for this study

Summary

This study will develop and evaluate the preliminary efficacy and cost-effectiveness of a mobile phone-delivered psychosocial intervention for opioid-dependent adults (N=219) in methadone maintenance treatment (MMT). A three-arm, randomized clinical trial will evaluate the relative efficacy of: (1) standard MMT; (2) standard MMT plus the mobile intervention; and (3) a mobile-based control condition on the primary outcomes of treatment retention and opioid use (assessed via urine toxicology). If results are promising, this novel therapeutic tool may have a tremendous impact on improving access to and effectiveness of substance abuse treatment in a variety of other populations (and could also be adapted for an array of other behavioral health applications), while significantly limiting costs.

Conditions

Interventions

BEHAVIORAL

standard treatment

the standard drug counseling offered to patients at the study site's methadone maintenance program

BEHAVIORAL

MTS (Mobile Therapeutic System)

a novel, interactive, mobile phone-delivered psychosocial intervention designed to promote skills acquisition and reduce drug use among adults in methadone maintenance treatment

BEHAVIORAL

mobile control

a mobile phone-based application that directs participants to the NIDA website's homepage

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • National Development and Research Institutes, Inc.

    lead OTHER

Principal Investigators

  • Michelle Acosta, Ph.D. · National Development and Research Institutes (NDRI)

  • Lisa A. Marsch, Ph.D. · Dartmouth College

  • Honoria Guarino, Ph.D. · National Development and Research Institutes (NDRI)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-11-30
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01632982 on ClinicalTrials.gov